Page 36 - FIMM_Brochure_2022
P. 36
Research
Director
Katja Kivinen
appointed
head of Covid-19 HGI project
FIMM
Technology
Professor Centre Caroline Heckman
Mark Daly appointed
nominated
Director Research Director,
of FIMM Precision Medicine
iCAN:
Academy
of Finland
Flagship ERC Starting Grant
meets Research Director (2019–26) to Andrea Ganna FIMM meets
a event Janna Saarela Pharma webinars
ting Grant appointed Director
g Tang of NCMM Intervene
FIMM-EMBL Group FInnGen study H2020 project
Leaders Andrea enters phase 2
Ganna, Esa Pitkänen with 12 pharma
AoF Centre of & Hanna Ollila partners
Excellence in Vision: Foundational science, tech-
Complex Diseases nology and data developed in FIMM’s
first 15 years are positively impacting
FinnGen Study VEIL.AI spinout FIMM is main
begins with company Finnish provider the healthcare of Finnish citizens
of SARS-CoV-2 and delivering molecular medicine
7 pharma partners sequencing for THL
solutions globally.
016 2018 2020 2022
2017 2019 2021 2030
FIMM joins HiLIFE New SAB EMBL Delegation
SAB Visit nominated Visit & Mini-
symposium
FIMM hosts SAB Visit SAB Visit
the 8th Nordic EMBL FIMM hosts
Partnership Meeting 250+ the EU-LIFE
Strategy
Meeting